Lidocaine Hydrochloride Noridem (Lidocaine Hydrochloride Monohydrate)

Lidocaine works by blocking voltage‑gated sodium channels on nerve membranes, stabilizing them in an inactive state. This prevents the initiation and propagation of action potentials, thereby inhibiting nerve impulse transmission and producing localized loss of sensation and pain relief.

The appropriate dose of Lidocaine Hydrochloride Noridem is determined by the prescribing clinician based on the intended route, patient characteristics, and the specific procedure. Healthcare professionals calculate the dose to stay within established safety limits for each administration method.

Safety data for Lidocaine Hydrochloride Noridem in pregnancy and lactation are limited, and the product is classified as having an unknown pregnancy category. It should be used only if the potential benefit justifies any potential risk to the fetus or infant, and clinicians should assess each case individually.

To order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request verification of trade or institutional credentials. After confirmation, the team provides pricing, availability, shipping details (including cold‑chain if required) and assists with import documentation.

Compared with longer‑acting amide anesthetics such as bupivacaine, lidocaine has a faster onset but a shorter duration of action, making it suitable for procedures requiring rapid anesthesia and quicker recovery. Its safety profile is well‑established, though higher doses may increase the risk of CNS and cardiac toxicity relative to some alternatives.

Lidocaine Hydrochloride Noridem should be stored at ambient temperature, below 25 °C, in its original packaging. Protect the container from direct sunlight, moisture and extreme temperature fluctuations. Ensure the vial or ampoule remains sealed until use to maintain sterility.

The product is supplied as a sterile solution for injection and can be administered via epidural, intradermal or intramuscular routes. Administration technique follows standard aseptic procedures, and the specific route is selected by the clinician according to the clinical indication and patient needs.

Serious adverse events include central nervous system toxicity such as seizures, cardiovascular complications like arrhythmias or cardiac arrest, severe allergic reactions including anaphylaxis, and rare cases of methemoglobinemia. Prompt recognition and supportive management are essential if these events occur.

Patients with a known hypersensitivity to lidocaine or other amide‑type local anesthetics should avoid this product. It is also contraindicated in individuals with severe heart block, uncorrected ventricular arrhythmias, or those receiving class I antiarrhythmic drugs without careful monitoring.